Patient Guide: A Worldwide Cancer Registry Enrolling Participants Profiled With a Next-Generation Sequencing Test

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 135 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT04529122
Status: 🟢 Enrolling Now
Condition: Solid Tumours
Phase: Not Specified

Where You Can Participate

This study is available at 135 locations across the country.

Top locations include:
  • • Buenos Aires,
  • • Buenos Aires,
  • • Graz,
  • • And 132 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Worldwide Cancer Registry Enrolling Participants Profiled With a Next-Generation Sequencing Test - Join Clinical Trial NCTNCT04529122

How to Join This Clinical Trial - NCTNCT04529122

Learn how to participate in this Not Specified trial studying an investigational therapy for Solid Tumours. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Solid Tumours. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Solid Tumours
Treatment Being Tested
Investigational treatment
Study Phase
Not Specified - Research study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT04529122 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 135 locations. Find a study site near you:

Clinical Research Site

Buenos Aires, 1426 - Argentina

Status: RECRUITING

Clinical Research Site

Buenos Aires, C1431FWN - Argentina

Status: RECRUITING

Clinical Research Site

Graz, 8036 - Austria

Status: RECRUITING

Clinical Research Site

Porto Alegre, Rio Grande do Sul 90035-001 - Brazil

Status: RECRUITING

Clinical Research Site

São Paulo, São Paulo 01246-000 - Brazil

Status: RECRUITING

Clinical Research Site

São Paulo, São Paulo 01323-903 - Brazil

Status: RECRUITING

Clinical Research Site

Rio de Janeiro, - Brazil

Status: RECRUITING

Clinical Research Site

São Paulo, 01321-00 - Brazil

Status: RECRUITING

Clinical Research Site

Calgary, Alberta T2N 4N2 - Canada

Status: RECRUITING

Clinical Research Site

Ottawa, Ontario K1H 8L6 - Canada

Status: RECRUITING

And 125 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this Not Specified clinical trial for Solid Tumours:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships